Approximately half of men with metastatic castration-resistant prostate cancer and BRCA1 or BRCA2 mutations do not receive medications that could improve their survival.Poly (adenosine ...
Once E3 tags CYP17A1, the cell uses its proteasome to break down the enzyme entirely. One major advantage of PROTACs is that ...
A multicenter clinical study in Austria has shown that a new, highly precise ultrasound approach can successfully target and ...
Oncologists and urologists identified several barriers to treatment intensification for metastatic castration-sensitive ...
Movember, widely recognised for its moustache-led movement to raise awareness of prostate cancer, testicular cancer, and ...
The identification of 20 causal plasma proteins for prostate cancer represents a critical step toward addressing the need for improved diagnostic specificity and reveals promising new targets for ...
Turmeric, a golden spice, offers potent antioxidant and anti-inflammatory benefits through its compound curcumin. However, ...